A. Hartemann

发表

A Fully Automated Web-Based Program Improves Lifestyle Habits and HbA1c in Patients With Type 2 Diabetes and Abdominal Obesity: Randomized Trial of Patient E-Coaching Nutritional Support (The ANODE Study)

Jean-Michel Oppert, Philippe Giral, Michel Marre, 2017, Journal of medical Internet research.

Factors associated with oral health‐related quality of life in patients with diabetes

A. Hartemann, J. Azerad, F. Anagnostou, 2018, Australian dental journal.

Association of peripheral neuropathy with circulating advanced glycation end products, soluble receptor for advanced glycation end products and other risk factors in patients with type 2 diabetes

A. Hartemann, P. Gillery, S. Jaisson, 2014, Diabetes/metabolism research and reviews.

Association between metformin use and below-the-knee arterial calcification score in type 2 diabetic patients

P. Cluzel, Z. Massy, A. Hartemann, 2017, Cardiovascular Diabetology.

Optimal wound closure of diabetic foot ulcers with early initiation of TLC-NOSF treatment: post-hoc analysis of Explorer.

M. Edmonds, A. Hartemann, J. Martini, 2019, Journal of wound care.

Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review

C. Attinger, W. Jeffcoate, F. Game, 2016, Diabetes/metabolism research and reviews.

Lower-extremity arterial revascularization: Is there any evidence for diabetic foot ulcer-healing?

P. Lermusiaux, A. Hartemann, J. Gaudric, 2016, Diabetes & metabolism.

Variability in clinical presentation of diabetes mellitus during anti-PD-1 immunotherapy.

A. Hartemann, F. Andreelli, A. Boudifa, 2020, Diabetes & metabolism.

Effectiveness of interventions to enhance healing of chronic foot ulcers in diabetes: a systematic review

C. Attinger, K. Dhatariya, V. Driver, 2020, Diabetes/metabolism research and reviews.

Guidelines on use of interventions to enhance healing of chronic foot ulcers in diabetes (IWGDF 2019 update)

C. Attinger, K. Dhatariya, V. Driver, 2020, Diabetes/metabolism research and reviews.

Serum concentration and vascular expression of adiponectin are differentially associated with the diabetic calcifying peripheral arteriopathy

Z. Massy, A. Hartemann, C. Funck-Brentano, 2019, Diabetology & Metabolic Syndrome.

Erratum: Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein

Z. Massy, A. Hartemann, S. Liabeuf, 2015, Cardiovascular Diabetology.

Vascular calcification in patients with type 2 diabetes: the involvement of matrix Gla protein

Z. Massy, A. Hartemann, S. Liabeuf, 2014, Cardiovascular Diabetology.

Below-knee arterial calcification in type 2 diabetes: association with receptor activator of nuclear factor κB ligand, osteoprotegerin, and neuropathy.

P. Cluzel, M. Komajda, Z. Massy, 2014, The Journal of clinical endocrinology and metabolism.

A unique CD8(+) T lymphocyte signature in pediatric type 1 diabetes.

P. van Endert, Y. Hamel, A. Hartemann, 2016, Journal of autoimmunity.

The Charcot foot in diabetes.

Lee C. Rogers, D. Armstrong, W. Jeffcoate, 2011, Journal of the American Podiatric Medical Association.

The Charcot Foot in Diabetes

Lee C. Rogers, D. Armstrong, W. Jeffcoate, 2011, Diabetes Care.

Higher parathyroid hormone levels are associated with increased below-the-knee arterial calcification in type 2 diabetes.

P. Cluzel, Z. Massy, A. Hartemann, 2017, Diabetes & metabolism.

Clinical characteristics and diagnostic criteria of maturity-onset diabetes of the young (MODY) due to molecular anomalies of the HNF1A gene.

C. Bellanné-Chantelot, J. Timsit, A. Hartemann, 2011, The Journal of clinical endocrinology and metabolism.

Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes

Z. Massy, A. Hartemann, C. Funck-Brentano, 2020, PloS one.

Correction: Inactive matrix gla protein plasma levels are associated with peripheral neuropathy in Type 2 diabetes

Z. Massy, A. Hartemann, C. Funck-Brentano, 2020, PloS one.

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes

A. Hartemann, F. Foufelle, P. Ferré, 2020, Cell reports. Medicine.

Influence of peripheral arterial occlusive disease on the Neuropad® test performance in patients with diabetes

A. Hartemann, C. Aubert, O. Bourron, 2013, Diabetic medicine : a journal of the British Diabetic Association.

SMRT-GPS2 corepressor pathway dysregulation coincides with obesity-linked adipocyte inflammation.

K. Clément, E. Treuter, A. Hartemann, 2013, The Journal of clinical investigation.

Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.

A. Hartemann, F. Andreelli, C. Ciangura, 2019, Diabetes technology & therapeutics.

Gestational diabetes and adverse perinatal outcomes from 716,152 births in France in 2012

F. Alla, A. Hartemann, A. Weill, 2017, Diabetologia.

A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes

D. Armstrong, W. Jeffcoate, D. G. Armstrong, 2012, Diabetes/metabolism research and reviews.

Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study

P. Cluzel, Z. Massy, A. Hartemann, 2020, Cardiovascular Diabetology.

Association of thyroid-stimulating hormone with corrected QT interval variation: A prospective cohort study among patients with type 2 diabetes.

F. Badilini, M. Vaglio, A. Hartemann, 2021, Archives of cardiovascular diseases.

The association between macrovascular complications and intensive care admission, invasive mechanical ventilation, and mortality in people with diabetes hospitalized for coronavirus disease-2019 (COVID-19)

Ho Yee Cheung, James D. Clark, May Thin Khine, 2022, Cardiovascular Diabetology.

Association of Type B Insulin Resistance and Type 1 Diabetes Resulting in Ketoacidosis

C. Vigouroux, A. Hartemann, O. Bourron, 2012, Diabetes Care.

Limitations of IL-2 and Rapamycin in Immunotherapy of Type 1 Diabetes

O. Boyman, A. Hartemann, E. Piaggio, 2013, Diabetes.

Response Letter to the Editor from Woolcott & Castilla-Bancayán:Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults

P. Chanson, Kankoé Sallah, S. Czernichow, 2021, The Journal of clinical endocrinology and metabolism.

Barriers to preventive and curative foot care behaviors in person with diabetes. Suggestions for therapeutic patient education

C. Marchand, J. D'ivernois, A. Hartemann, 2012 .

IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes

C. Attinger, W. Jeffcoate, F. Game, 2016, Diabetes/metabolism research and reviews.

IWGDF Guideline on interventions to enhance healing of foot ulcers in persons with diabetes

C. Attinger, K. Dhatariya, F. Game, 2019 .

Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.

D. Klatzmann, A. Hartemann, G. Bensimon, 2013, The lancet. Diabetes & endocrinology.

Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Luis Pedro Coelho, P. Bork, F. Bäckhed, 2020, Nature Communications.

The onset of acute Charcot neuroarthropathy during pregnancy in patients with type 1 diabetes

A. Hartemann, A. Penfornis, D. Dardari, 2020, Endocrinology, diabetes & metabolism case reports.

Interleukin-2 and type 1 diabetes: new therapeutic perspectives.

A. Hartemann, O. Bourron, A Hartemann, 2012, Diabetes & metabolism.

Influence of peripheral vascular calcification on efficiency of screening tests for peripheral arterial occlusive disease in diabetes—a cross‐sectional study

P. Cluzel, A. Hartemann, P. Michel, 2014, Diabetic medicine : a journal of the British Diabetic Association.

Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol

Patrice Cacoub, Francis Berenbaum, Eric Vicaut, 2018, BMJ Open.

Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

D. Klatzmann, A. Hartemann, T. Malek, 2015, Journal of autoimmunity.

Loss of immune tolerance to IL-2 in type 1 diabetes

Olivier Boyer, Roberto Mallone, John M. Lindner, 2016, Nature Communications.

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Luis Pedro Coelho, P. Bork, V. Tremaroli, 2020, Nature.

Pregnant type 1 diabetes women with rises in C-peptide display higher levels of regulatory T cells: A pilot study.

D. Klatzmann, A. Hartemann, F. Andreelli, 2020, Diabetes & metabolism.

Low-dose IL-2 in children with recently diagnosed type 1 diabetes: a Phase I/II randomised, double-blind, placebo-controlled, dose-finding study

E. Vicaut, M. Polak, D. Klatzmann, 2020, Diabetologia.

Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T 1 D patients Running head : dose-dependent low dose IL-2 immunoregulation

D. Klatzmann, A. Hartemann, T. Malek, 2017 .

Interleukin 2 in the Pathogenesis and Therapy of Type 1 Diabetes

D. Klatzmann, A. Hartemann, M. Rosenzwajg, 2014, Current Diabetes Reports.

Rapid glycemic regulation in poorly controlled patients living with diabetes, a new associated factor in the pathophysiology of Charcot’s acute neuroarthropathy

F. Jaisser, A. Hartemann, F. Foufelle, 2020, PloS one.

Management of patients hospitalized for diabetic foot infection: results of the French OPIDIA study.

A. Hartemann, J. Lavigne, J. Richard, 2011, Diabetes & metabolism.

Chronic Pain with Neuropathic Characteristics in Diabetic Patients: A French Cross-Sectional Study

D. Bouhassira, A. Hartemann, M. Letanoux, 2013, PloS one.

Delay discounting of gains and losses, glycemic control and therapeutic adherence in type 2 diabetes

M. Pessiglione, F. Limosin, G. Reach, 2016, Behavioural Processes.

Impaired hypoxic ventilatory drive induced by diabetic autonomic neuropathy, a cause of misdiagnosed severe cardiac events: brief report of two cases

A. Hartemann, O. Bourron, F. Phan, 2020, BMC Cardiovascular Disorders.

Painful diabetic neuropathy: diagnosis and management.

H. Gin, D. Bouhassira, N. Attal, 2011, Diabetes & metabolism.

Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus

M. Marre, R. Roussel, F. Hyafil, 2018, Cardiovascular Diabetology.

Relationship between cardiac microvascular dysfunction measured with 82 Rubidium-PET and albuminuria in patients with diabetes mellitus

M. Marre, R. Roussel, F. Hyafil, 2018 .

Burden of diabetic foot disorders, guidelines for management and disparities in implementation in Europe: a systematic literature review

A. Hartemann, M. K. Siddiqui, Agnes Hartemann, 2014, Diabetes/metabolism research and reviews.

Diabetic foot ulcer management in a multidisciplinary foot centre: one-year healing, amputation and mortality rate.

P. Cluzel, A. Hartemann, G. Ha Van, 2020, Journal of wound care.

Cognitive and anxiety symptoms in screening for clinical depression in diabetes: a systematic examination of diagnostic performances of the HADS and BDI-SF.

O. Luminet, A. Hartemann, S. Sultan, 2010, Journal of affective disorders.

Consensus Reports

Lee C. Rogers, William H. Herman, Kirkman, 2011, Diabetes Care.

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

Chris Day, Fritz Wrba, Debbie Lawlor, 2016, Alimentary pharmacology & therapeutics.

Evaluation of two therapeutic patient education programs for prevention of diabetic foot ulcers

C. Marchand, J. D'ivernois, A. Hartemann, 2018 .

Clinical and Metabolic Features of Adult-Onset Diabetes Caused by ABCC8 Mutations

G. Charpentier, P. Froguel, M. Polak, 2012, Diabetes Care.

Clinical andMetabolic Features of Adult-Onset Diabetes Caused by ABCC 8 Mutations

G. Charpentier, P. Froguel, M. Polak, 2011 .

Multifocal (tarsus and knee) activation of neuroarthropathy following rapid glycaemic correction

F. Jaisser, A. Hartemann, F. Foufelle, 2019 .

Fast, accurate and easy-to-teach QT interval assessment: The triplicate concatenation method.

F. Badilini, M. Vaglio, A. Hartemann, 2017, Archives of cardiovascular diseases.

Treatment of chronic plantar ulcer of the diabetic foot using an irremovable windowed fibreglass cast boot: prospective study of 177 patients

P. Pradat-Diehl, A. Hartemann, G. Ha Van, 2015, Diabetes/metabolism research and reviews.

Statin therapy is associated with lower prevalence of gut microbiota dysbiosis

Luis Pedro Coelho, P. Bork, V. Tremaroli, 2020, Nature.

Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis

A. Idbaih, Jacques Young, C. Vigouroux, 2019, Case reports in endocrinology.

Diabetes increases severe COVID-19 outcomes primarily in younger adults Age and diabetes in COVID-19 severity

P. Chanson, S. Czernichow, R. Roussel, 2021, The Journal of clinical endocrinology and metabolism.

Author Correction: Imidazole propionate is increased in diabetes and associated with dietary patterns and altered microbial ecology

Luis Pedro Coelho, P. Bork, F. Bäckhed, 2020, Nature Communications.

Diabetes Increases Severe COVID-19 Outcomes Primarily in Younger Adults.

P. Chanson, Kankoé Sallah, S. Czernichow, 2021, The Journal of clinical endocrinology and metabolism.

Prevalence and description of the skin reactions associated with adhesives in diabetes technology devices in an adult population: results of the CUTADIAB study.

R. Roussel, A. Hartemann, J. Gautier, 2023, Diabetes technology & therapeutics.

Head-to-head comparison of the diagnostic performances of Rubidium-PET and SPECT with CZT camera for the detection of myocardial ischemia in a population of women and overweight individuals

R. Roussel, F. Hyafil, D. Le Guludec, 2018, Journal of Nuclear Cardiology.

Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients

A. Redheuil, N. Kachenoura, M. Zarai, 2021, Cardiovascular Diabetology.

Physicians’ understanding of patients’ personal representations of their diabetes: Accuracy and association with self-care

Franck Zenasni, F. Zenasni, A. Hartemann, 2011, Psychology & health.

Five-year mortality in patients with diabetic foot ulcer during 2009-2010 was lower than expected.

A. Hartemann, Coralie Amadou, C. Aubert, 2019, Diabetes & metabolism.

Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: a case series.

A. Hartemann, S. Jacqueminet, B. Coffin, 2023, Diabetes & Metabolism.

Cost-effectiveness of 82-Rubidium PET myocardial perfusion imaging for the diagnosis of myocardial ischemia depending on the prevalence of coronary artery disease

I. Durand-zaleski, R. Roussel, F. Hyafil, 2023, EJNMMI Research.

Type B Insulin-resistance syndrome: a cause of reversible autoimmune hypoglycaemia

C. Vigouroux, A. Hartemann, F. Andreelli, 2014, The Lancet.

Importance of alternative-site blood glucose testing in the diagnosis of artifactual hypoglycaemia in systemic scleroderma.

A. Hartemann, F. Andreelli, H. Mosbah, 2017, Diabetes & Metabolism.